The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network
Open accessAbstract
Carbapenem-resistant Enterobacteriaceae (CRE) infection is highly endemic in China, but estimates of the infection burden are lacking. We established the incidence of CRE infection from a multicenter study that covered 25 tertiary hospitals in 14 provinces. CRE cases defined as carbapenem-nonsusceptible Citrobacter freundii , Escherichia coli , Enterobacter cloacae , or Klebsiella pneumoniae infections during January to December 2015 were collected and reviewed from medical records. Antimicrobial susceptibility testing and carbapenemase gene identification were performed. Among 664 CRE cases, most were caused by K. pneumoniae (73.9%), followed by E. coli (16.6%) and E. cloacae (7.1%). The overall CRE infection incidence per 10,000 discharges was 4.0 and differed significantly by region, with the highest in Jiangsu (14.97) and the lowest in Qinghai (0.34). Underlying comorbidities were found in 83.8% of patients; the median patient age was 62 years (range, 45 to 74 years), and 450 (67.8%) patients were male. Lower respiratory tract infections (65.4%) were the most common, followed by urinary tract infection (16.6%), intra-abdominal infection (7.7%), and bacteremia (7.7%). The overall hospital mortality rate was 33.5%. All isolates showed nonsusceptibility to carbapenems and cephalosporins. The susceptibility rate of polymyxin B was >90%. Tigecycline demonstrated a higher susceptibility rate against E. coli than against K. pneumoniae (90.9% versus 40.2%). Of 155 clinical isolates analyzed, 89% produced carbapenemases, with a majority of isolates producing KPC (50%) or NDM (33.5%)-type beta-lactamases among K. pneumoniae and E. coli . The incidence of CRE infection in China was 4.0 per 10,000 discharges. The patient-based disease burden in tertiary hospitals in China is severe, suggesting an urgent need to enhance infection control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Horan, T. C., Andrus, M., & Dudeck, M. A. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2008.03.002 · Cited by 6,626
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Gupta, N., Limbago, B. M., Patel, J. B., & Kallen, A. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir202 · Cited by 1,033
Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,016
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Cantón, R., Akóva, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., Livermore, D. M., Miriagou, V., Naas, T., Rossolini, G. M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03821.x · Cited by 883
Grundmann, H., Glasner, C., Albiger, B., Aanensen, D. M., Tomlinson, C. T., Andrasević, A. T., Cantón, R., Carmeli, Y., Friedrich, A. W., Giske, C. G., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30257-2 · Cited by 662
Daikos, G. L., Tsaousi, S., Tzouvelekis, L. S., Anyfantis, I., Psichogiou, M., Argyropoulou, A., Stefanou, I., Sypsa, V., Miriagou, V., Nepka, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02166-13 · Cited by 597
Cited by
The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae
Wang, G., Zhao, G., Chao, X., Xie, L., & Wang, H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176278 · Cited by 591
Self-citationKern, W. V., & Rieg, S. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.10.031 · Cited by 355
Wang, Q., Wang, X., Wang, J., Ouyang, P., Jin, C., Wang, R., Zhang, Y., Jin, L., Chen, H., Wang, Z., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy660 · Cited by 349
Self-citationMa, J., Song, X., Li, M., Yu, Z., Cheng, W., Yu, Z., Zhang, W., Zhang, Y., Shen, A., Sun, H., et al. (2023) · Microbiological Research · doi:10.1016/j.micres.2022.127249 · Cited by 308
Self-citationKumudunie, W. G. M., Wijesooriya, L. I., Namalie, K. D., Sunil-Chandra, N. P., & Wijayasinghe, Y. S. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.04.010 · Cited by 21
Metadata
- Authors
- Zhang, Y., Wang, Q., Yin, Y., Chen, H., Jin, L., Gu, B., Xie, L., Yang, C., Ma, X., Li, H., Li, W., Zhang, X., Liao, K., Man, S., Wang, S., Wen, H., Li, B., Guo, Z., Tian, J., Pei, F., Liu, L., Zhang, L., Zou, C., Hu, T., Cai, J., Yang, H., Huang, J., Jia, X., Huang, W., Cao, B., & Wang, H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2018-02
- Volume
- 62
- Issue
- 2
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2790271712
- Cited by
- 450
- References
- 23
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network. https://app.cochat.ai/papers/10.1128/aac.01882-17
- The paper
- Zhang, Y., Wang, Q., Yin, Y., Chen, H., Jin, L., Gu, B., Xie, L., Yang, C., Ma, X., Li, H., Li, W., Zhang, X., Liao, K., Man, S., Wang, S., Wen, H., Li, B., Guo, Z., Tian, J., . . . Wang, H. (2018). Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01882-17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.